{"id":"https://openalex.org/A5117101427","orcid":"https://orcid.org/0009-0003-3269-7914","observed_orcids":["https://orcid.org/0009-0003-3269-7914"],"display_name":"Ioana Mitrofan","raw_author_names":["Ioana Mitrofan"],"full_name":"Ioana Mitrofan","works_count":4,"cited_by_count":5,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":2,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117101427","orcid":"https://orcid.org/0009-0003-3269-7914","observed_orcids":["https://orcid.org/0009-0003-3269-7914"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210088791","ror":"https://ror.org/00afdp487","display_name":"Victor Babe\u0219 University of Medicine and Pharmacy Timi\u0219oara","country_code":"RO","type":"education","lineage":["https://openalex.org/I4210088791"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210088791","ror":"https://ror.org/00afdp487","display_name":"Victor Babe\u0219 University of Medicine and Pharmacy Timi\u0219oara","country_code":"RO","type":"education","lineage":["https://openalex.org/I4210088791"]}],"topics":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","count":4,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","count":3,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10578","display_name":"Supramolecular Chemistry and Complexes","count":3,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","count":1,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","count":1,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","value":2.07e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","value":1.31e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10578","display_name":"Supramolecular Chemistry and Complexes","value":9.8e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","value":8e-07,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","value":7e-07,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"2780591200","wikidata":"https://www.wikidata.org/wiki/Q412534","display_name":"Carvedilol","score":0.9412373304367065},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.7181000113487244},{"id":"2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","score":0.7139452695846558},{"id":"108204754","wikidata":"https://www.wikidata.org/wiki/Q353392","display_name":"Adduct","score":0.4510999917984009},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.2912999987602234}],"counts_by_year":[{"year":2025,"works_count":4,"oa_works_count":3,"cited_by_count":2},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":3}],"display_name_alternatives":["Ioana Mitrofan"],"block_key":"i mitrofan","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117101427","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5117101427","updated_date":"2026-11-16T12:53:42","created_date":"2025-04-11T00:00:00"}
